Pharmacy Specialty Pharmacy and Biologics 1 — Questions and Answers
Question 1: A biologic medication differs from a small-molecule drug primarily because it is:
- Synthesized via simple chemical reactions and has a small molecular weight
- A large, complex molecule derived from living cells that is difficult to replicate exactly (Correct answer)
- Always administered orally
- Approved through the ANDA pathway as a generic
Correct answer: A large, complex molecule derived from living cells that is difficult to replicate exactly
Biologics (e.g., monoclonal antibodies, insulin analogs) are large, complex molecules produced from living organisms. Their complexity means even minor manufacturing changes can affect efficacy and immunogenicity.
Question 2: A biosimilar is approved under the FDA's Biologics Price Competition and Innovation Act (BPCIA) by demonstrating:
- Identical molecular structure to the reference biologic
- No clinically meaningful differences in safety, purity, and potency from the reference product (Correct answer)
- Bioequivalence through the same ANDA process as small-molecule generics
- Lower cost of production compared to the reference biologic
Correct answer: No clinically meaningful differences in safety, purity, and potency from the reference product
Biosimilars must demonstrate no clinically meaningful differences from the reference biologic in safety, purity, and potency. They cannot be 'identical' due to biological variability — hence 'biosimilar,' not 'biogeneric.'
Question 3: TNF-alpha inhibitors (e.g., adalimumab/Humira) are used in specialty pharmacy for conditions such as:
- Type 1 diabetes and hypothyroidism
- Rheumatoid arthritis, Crohn's disease, and psoriasis (Correct answer)
- Hypertension and heart failure
- COPD and asthma only
Correct answer: Rheumatoid arthritis, Crohn's disease, and psoriasis
TNF-alpha inhibitors block tumor necrosis factor-alpha, a key inflammatory cytokine. They are used for autoimmune conditions including RA, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.
Question 4: Before initiating a TNF-alpha inhibitor, patients should be screened for:
- G6PD deficiency
- Latent tuberculosis (TB) (Correct answer)
- Glucose-6-phosphate dehydrogenase deficiency
- Gilbert's syndrome
Correct answer: Latent tuberculosis (TB)
TNF-alpha inhibitors suppress the immune system and can reactivate latent tuberculosis. A tuberculin skin test (TST) or IGRA and chest X-ray are required before starting therapy.
Question 5: Which storage requirement is typical for most biologic medications?
- Room temperature (15–25°C) and away from light
- Refrigeration at 2–8°C; many cannot be frozen (Correct answer)
- Frozen at −20°C for long-term stability
- No special storage required
Correct answer: Refrigeration at 2–8°C; many cannot be frozen
Most biologic drugs require refrigeration at 2–8°C. Freezing can disrupt the complex protein structure, leading to aggregation, loss of potency, or increased immunogenicity.
Question 6: The specialty pharmacy model provides value-added services such as:
- Dispensing only — no additional services provided
- Patient adherence programs, prior authorization support, clinical monitoring, and financial assistance coordination (Correct answer)
- OTC medication recommendations exclusively
- Compounding all medications on site
Correct answer: Patient adherence programs, prior authorization support, clinical monitoring, and financial assistance coordination
Specialty pharmacies coordinate complex services including prior authorization, patient education, adherence monitoring, clinical outcome tracking, cold-chain distribution, and patient assistance programs for high-cost therapies.
Pharmacy Specialty Pharmacy and Biologics 1
A biologic medication differs from a small-molecule drug primarily because it is: